Istituto Biochimico Italiano Giovanni Lorenzini SpA DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

1 News #PharmaBuzz

media
1 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

10 All APIs, 4 USDMF, 7 CEP/COS

10 All APIs
4 USDMF
7 CEP/COS

FINISHED DOSAGE FORMULATIONS

108 FDF Dossiers, 27 FDA Orange Book, 81 Europe

108 FDF Dossiers
27 FDA Orange Book
81 Europe

INSPECTIONS & REGISTRATIONS

3 FDA, 1 GDUFA

inspections
3 FDA
1 GDUFA

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ibi was founded in 1918 by Professor Giovanni Lorenzini. A long tradition in the field of scientific research together with the innovative technologies applied and the level of care and attention to production have given Ibi its reputation for reliability and high quality. The Ibi plant covers an area of 18,000 square metres, on which a new building is entirely dedicated to the production of ß-lactamics. Offering state of the art service and technology, Ibi is among the top ten Italian companies in toll manufacturing. Today Ibi is present in over 30 countries, exporting two thirds of its total production. It is one of few companies not producing in the United States that has obtained FDA approval for the production of sterile penicillin for the American market. Ibi has developed a new distribution strategy directly to hospitals, entrusting the sales of its products to a special new organization, Ibisqus, created in joint venture and present in the UK, Germany and Italy. Ibi is present on the Italian market with a variety of products ranging from sterile penicillin to food supplements. It is well known for the reputation of its products in the area of antinfective therapy and gastroenterology. A network of highly qualified scientific informers enables Ibi to contact the universe of gastroenterologist specialist and 55% of infectious disase specialist. Ibi provides directly 4000 pharmacies. In addition to its tradition and quality, today Ibi is proud of its innovative laboratories and expert researchers, able to offer new services in the fields of Biotechnology and Nano-medicine, especially in the development of processes for the production of recombinant proteins in cGMP and in the planning and production of new delivery systems. Years of experience in formulation studies, in the development of production processes and in industrial scale-up enable Ibi to face the new challenges on the pharmaceutical market with confidence. Ibi produces its products in conformity with the regulations of the European Pharmacopoeia and the cGMP norms. It is, in addition, certified by the most demanding Health Authorities: AIFA, FDA, TGA and MCA.